Summary
Intuitive Surgical, Inc. (ISRG) filed an 8-K on March 13, 2013, to report on its medical device reporting practices. This filing includes a press release dated March 13, 2013, which addresses how the company is responding to FDA inquiries and concerns regarding the reporting of adverse events associated with its da Vinci Surgical System. The company is providing this information to offer transparency and clarity to stakeholders about their commitment to patient safety and regulatory compliance. While this 8-K does not contain new financial results or significant operational updates, it signals the company's proactive engagement with regulatory bodies concerning device reporting. Investors should note that the detailed information regarding these reporting practices is contained within the press release, which is incorporated by reference. This event underscores the importance Intuitive Surgical places on adhering to medical device reporting regulations and maintaining open communication with the Food and Drug Administration (FDA).
Key Highlights
- 1Intuitive Surgical filed an 8-K on March 13, 2013, to disclose information regarding its medical device reporting practices.
- 2The filing includes a press release dated March 13, 2013, which is incorporated by reference.
- 3The press release addresses Intuitive Surgical's communication and response to FDA inquiries concerning adverse event reporting for the da Vinci Surgical System.
- 4The company is emphasizing its commitment to patient safety and regulatory compliance.
- 5This report is primarily informational, focusing on the company's regulatory interactions rather than new financial or operational performance.
- 6The Senior Vice President and Chief Financial Officer, Marshall L. Mohr, signed the report.